공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

콘택트 렌즈 시장 : 성장, 동향, COVID-19의 영향, 예측(2021-2026년)

Contact Lenses Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

리서치사 Mordor Intelligence Pvt Ltd
발행일 2021년 03월 상품 코드 391472
페이지 정보 영문
가격
US $ 4,250 ₩ 4,788,000 PDF (Single User License)
US $ 4,750 ₩ 5,352,000 PDF (Team License: Up to 7 Users)
US $ 6,000 ₩ 6,760,000 PDF (Site License)
US $ 7,500 ₩ 8,451,000 PDF (Corporate License)


콘택트 렌즈 시장 : 성장, 동향, COVID-19의 영향, 예측(2021-2026년) Contact Lenses Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)
발행일 : 2021년 03월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계 콘택트 렌즈 시장은 안질환 이환율 상승, 가처분소득 상승 등에 의해 성장하고 있습니다. 콘택트 렌즈는 관리하기 어려운 안경을 대신해서 사용되고 있으며, 지난 10년간 상당한 기술 혁신이 행해졌습니다.

세계의 콘택트 렌즈(Contact Lenses) 시장에 대해 조사했으며, 시장 동향과 부문별 동향, 지역별 예측, 시장 진출기업 개요 등의 정보를 정리했습니다.

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 시장 역학

  • 시장 개요
  • 시장 성장 촉진요인
    • 안질환 이환율 상승
    • 미용에 심취
    • 가처분소득 상승
  • 시장 성장 저해요인
    • 대체기술의 이용 가능성
    • 렌즈와 관련된 합병증
  • 업계의 매력도 : Porter's Five Forces 분석

제5장 시장 세분화

  • 제품별
    • 소프트 콘택트 렌즈
    • 하이브리드 콘택트 렌즈
    • 가스 투과성 콘택트 렌즈
    • 기타
  • 사용별
    • 교정용
    • 치료용
    • 미용용
    • 인공기관용
  • 모달리티별
    • 기존
    • 일회용
  • 디자인별
  • 유통채널별
  • 지역별
    • 북미
    • 유럽
    • 아시아태평양
    • 중동 및 아프리카
    • 남미

제6장 경쟁 환경

  • 기업 개요
    • Staar Surgical
    • Novartis AG
    • Bausch Health Companies Inc.
    • Zeiss Group
    • The Cooper Companies
    • Essilor International SA
    • Hoya Corporation
    • Haohai Biological Technology
    • Johnson & Johnson Vision Care Inc..
    • SynergEyes Inc.

제7장 시장 기회와 향후 동향

LSH 19.03.20

The Contact Lenses Market is expected to register a CAGR of nearly 5% during the forecast period, with a revenue of approximately USD 9,785 million in 2020 and expected to reach 12,995 million by 2026.

The impact of COVID-19 on the market growth may be negative in the year 2020, due to a smaller number of eye care consultations. Moreover, the market may prevail with the normal growth rate in near future. For instance, as per the Centers for Disease Control and Prevention and the American Academy of Ophthalmology, it is estimated that there was a nearly 80% initial decrease in ophthalmology visits and that as of mid-June there was still a cumulative decrease in ophthalmology visits of 40% in the United States.

The growth of the contact lens market is attributed to the rising prevalence of optical disorders, the rising tendency to improve aesthetics and increasing disposable incomes. According to WHO, in 2019, it was estimated that around 2.2 billion people have vision impairment or blindness. Also, an emerging important cause of visual impairment in the developed regions of the world is uncorrected refractive errors. Rising geriatric population if further aggravating the prevalence of ophthalmic disorders, the leading causes of vision impairment are uncorrected refractive errors and cataracts, and most people with vision impairment are over the age of 50 years.

A significant increase in research and devlopment activities in the field of optometry and optics has been observed in the market. Advent such as the intoduction of dynamic soft contact lenses integrated with advanced technology have boosted the demand for contact lenses. For instance, in November 2018, IMEC and SEED Co. Ltd, an international R&D hub had colloborated to develop a smart contact lens. This contact lens will components, such as a LED light, an ultra-thin silicon microchip and radio-frequency antenna for wireless energy transfer.

The increasing product innovations have increased the adoption of contact lenses. For instance, In March 2019, Alcon Vision LLC launched AcrySof IQ PanOptix Trifocal IOL in the United States. This trifocal lens can be used for intermediate, distance, and near vision. Increasing developments in contact lenses with drug-delivering capabilities are further expected to drive the market demand over the forecast period. However, factors such as availability of alternative techniques and complications associated with lens is likely to hamper the market growth.

Key Market Trends

Corrective Contact Lenses are Expected to Exhibit the Significant Growth Rate over the Forecast Period

The outbreak of COVID-19 showed an impact on the corrective lenses segment because eye care services were significantly reduced due to social distancing measures taken by governments across the globe. However, the ophthalmology practices are being continued with preventive measures. In August 2020, in India, the Ministry of Health and Family Welfare proposed guidelines on safe ophthalmology practices in COVID-19 scenario such as eye-care facilities should ensure that tele-counseling and teleconsultation should be promoted to lessened patient visits or/and appointment system can be followed to call patients needing examination/eye procedures/investigations.

Corrective lenses are the lenses that have been made specifically to match the wearer's vision defects. The purpose of the corrective lens is being made to improve or correct the vision of people with farsightedness (hyperopia), nearsightedness (myopia), presbyopia, and astigmatism.

The rising product launch has increased the adoption of corrective contact lenses. In November 2019, the U.S. FDA approved Coopervision Inc.'s Misight 1 day, the first corrective contact lens designed to slow the progression of myopia, or near-sightedness, in children. The disposable, single use, soft contact lens is made for children who are diagnosed with myopia and begin Misight treatment at an early age.

With available vision correction solutions and rising awareness about vision impairment conditions, the demand for these devices is increasing. Even in the developed regions of the world, the trend seems to be still rising owing to growing vision correction, due to factors such as the growing geriatric population. For instance, according to the 2017-18 National Health Survey (NHS) of Australia, the percentage of the population with visual impairment has been rising over the past few years in Australia. This is expected to help the growth of the market.

North America is Expected to Dominate the Market Over the Forecast Period

For contact lenses specifically during COVID-19, with limited social interaction and travel restrictions, the reduction in typical usage occasions has resulted in a decrease in contact lens wear.

The United States and Canada have developed and well-structured healthcare systems. These systems also encourage research and development. The supportive government policies are encouraging global market players to enter the United States and Canada. As a result, these countries have the presence of many global market players.

Moreover, a rise in the number of visual inaccuracies is expected to drive the regional market growth. For instance, as per the statistics published by National Eye Institute,2019, around 1.3 million Americans are blind and 2.9 million have low vision; and an estimated 2.2 million Americans will be blind and around 5 million Americans will have low vision by 2030. Hence, an increase in eye disorders will lead to a growing demand for contact lenses.

Rising product innovation is also bodes well for regional market growth. For instance, in 2019, Bausch + Lomb announced the U.S. launch of Bausch + Lomb ULTRA Multifocal for Astigmatism contact lenses. In 2020, Alcon Canada strengthened its robust contact lens portfolio in Canada, by launching its innovative PRECISION1 daily disposable, silicone hydrogel (SiHy) contact lenses. Thus, with several developments by companies and demand by customers, the North American region is a highly attractive and stable region for the growth of companies and consumers about the contact lenses market

Competitive Landscape

The contact lenses market is highly competitive and consists of several major players. The presence of major market players, such as Essilor International SA, Novartis AG, Bausch Health Companies Inc., Zeiss Group, and The Cooper Companies are, in turn, increasing the overall competitive rivalry of the market. With moderate sustainable competitive advantage through innovative products and low competition between online and offline companies, moderate competitive rivalry is observed in this market.

The market participants enter into long-term partnerships with suppliers and distributors to gain competitive advantge and expand their product portfolio and geographical presence.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Introduction to Market Drivers and Restraints
  • 4.3 Market Drivers
    • 4.3.1 Increasing Burden of Optical Disorders
    • 4.3.2 Increasing Tendency to Enhance Aesthetics
  • 4.4 Market Restraints
    • 4.4.1 Availability of Alternative Techniques
    • 4.4.2 Complications Associated with Lens
  • 4.5 Industry Attractiveness - Porter's Fives Forces Analysis
    • 4.5.1 Threat of New Entrants
    • 4.5.2 Bargaining Power of Buyers/Consumers
    • 4.5.3 Bargaining Power of Suppliers
    • 4.5.4 Threat of Substitute Products
    • 4.5.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product Type
    • 5.1.1 Soft Contact Lenses
    • 5.1.2 Hybrid Contact Lenses
    • 5.1.3 Rigid Gas Permeable Contact Lenses
    • 5.1.4 Other Product Types
  • 5.2 By Usage
    • 5.2.1 Corrective Contact Lenses
    • 5.2.2 Therapeutic Contact Lenses
    • 5.2.3 Cosmetic Contact Lenses
    • 5.2.4 Prosthetic Contact Lenses
  • 5.3 By Modality
    • 5.3.1 Conventional
    • 5.3.2 Disposable
  • 5.4 By Design
    • 5.4.1 Spherical
    • 5.4.2 Toric
    • 5.4.3 Multifocal
    • 5.4.4 Other Designs
  • 5.5 Geography
    • 5.5.1 North America
      • 5.5.1.1 United States (By Product Type, By Usage, By Modality and By Design)
      • 5.5.1.2 Canada (By Product Type, By Usage, By Modality and By Design)
      • 5.5.1.3 Mexico (By Product Type, By Usage, By Modality and By Design)
    • 5.5.2 Europe
      • 5.5.2.1 United Kingdom (By Product Type, By Usage, By Modality and By Design)
      • 5.5.2.2 Germany (By Product Type, By Usage, By Modality and By Design)
      • 5.5.2.3 France (By Product Type, By Usage, By Modality and By Design)
      • 5.5.2.4 Italy (By Product Type, By Usage, By Modality and By Design)
      • 5.5.2.5 Spain (By Product Type, By Usage, By Modality and By Design)
      • 5.5.2.6 Rest of Europe (By Product Type, By Usage, By Modality and By Design)
    • 5.5.3 Asia-Pacific
      • 5.5.3.1 China (By Product Type, By Usage, By Modality and By Design)
      • 5.5.3.2 Japan (By Product Type, By Usage, By Modality and By Design)
      • 5.5.3.3 India (By Product Type, By Usage, By Modality and By Design)
      • 5.5.3.4 Australia (By Product Type, By Usage, By Modality and By Design)
      • 5.5.3.5 South Korea (By Product Type, By Usage, By Modality and By Design)
      • 5.5.3.6 Rest of Asia-Pacific (By Product Type, By Usage, By Modality and By Design)
    • 5.5.4 Middle-East and Africa
      • 5.5.4.1 GCC (By Product Type, By Usage, By Modality and By Design)
      • 5.5.4.2 South Africa (By Product Type, By Usage, By Modality and By Design)
      • 5.5.4.3 Rest of Middle-East and Africa (By Product Type, By Usage, By Modality and By Design)
    • 5.5.5 South America
      • 5.5.5.1 Brazil (By Product Type, By Usage, By Modality and By Design)
      • 5.5.5.2 Argentina (By Product Type, By Usage, By Modality and By Design)
      • 5.5.5.3 Rest of South America (By Product Type, By Usage, By Modality and By Design)

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Medical Optics, Inc.
    • 6.1.2 Alcon Vision LLC
    • 6.1.3 Bausch Health Companies Inc.
    • 6.1.4 Contamac
    • 6.1.5 Essilor International SA
    • 6.1.6 Haohai Biological Technology
    • 6.1.7 Hoya Corporation
    • 6.1.8 Johnson & Johnson Vision Care Inc.
    • 6.1.9 Medennium
    • 6.1.10 Novartis AG
    • 6.1.11 Polylite Sofclear
    • 6.1.12 Scrivens House
    • 6.1.13 Seed Co., Ltd.
    • 6.1.14 STAAR Surgical Company
    • 6.1.15 SynergEyes Inc.
    • 6.1.16 The Cooper Companies
    • 6.1.17 Zeiss Group

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top
전화 문의
F A Q